Brief: Concord Biotech Says HPRA Of Ireland Has Issued EUGMP Certificate For Co's Unit II At Dholka
05/06/2024 15:19
June 5 (Reuters) - Concord Biotech Ltd CONB.NS :
* CONCORD BIOTECH - HEALTH PRODUCT REGULATORY AUTHORITY OF
IRELAND
HAS ISSUED EUGMP CERTIFICATE FOR CO'S UNIT II AT DHOLKA,
AHMEDABAD
Source text for Eikon: ID:nBSE3Y0cvZ
Further company coverage: CONB.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Concord Biotech
See all newsIndia's Concord Biotech rises after board to consider bonus share issue
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval